1.Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
Jae Seung LEE ; Young Eun CHON ; Beom Kyung KIM ; Jun Yong PARK ; Do Young KIM ; Sang Hoon AHN ; Kwang-Hyub HAN ; Wonseok KANG ; Moon Seok CHOI ; Geum-Youn GWAK ; Yong-Han PAIK ; Joon Hyeok LEE ; Kwang Cheol KOH ; Seung Woon PAIK ; Hwi Young KIM ; Tae Hun KIM ; Kwon YOO ; Yeonjung HA ; Mi Na KIM ; Joo Ho LEE ; Seong Gyu HWANG ; Soon Sun KIM ; Hyo Jung CHO ; Jae Youn CHEONG ; Sung Won CHO ; Seung Ha PARK ; Nae-Yun HEO ; Young Mi HONG ; Ki Tae YOON ; Mong CHO ; Jung Gil PARK ; Min Kyu KANG ; Soo Young PARK ; Young Oh KWEON ; Won Young TAK ; Se Young JANG ; Dong Hyun SINN ; Seung Up KIM ;
Yonsei Medical Journal 2021;62(1):12-20
		                        		
		                        			 Purpose:
		                        			Alpha-fetoprotein (AFP) is a prognostic marker for hepatocellular carcinoma (HCC). We investigated the prognostic value of AFP levels in patients who achieved complete response (CR) to transarterial chemoembolization (TACE) for HCC. 
		                        		
		                        			Materials and Methods:
		                        			Between 2005 and 2018, 890 patients with HCC who achieved a CR to TACE were recruited. An AFP responder was defined as a patient who showed elevated levels of AFP (>10 ng/mL) during TACE, but showed normalization or a >50% reduction in AFP levels after achieving a CR. 
		                        		
		                        			Results:
		                        			Among the recruited patients, 569 (63.9%) with naïve HCC and 321 (36.1%) with recurrent HCC after complete resection were treated. Before TACE, 305 (34.3%) patients had multiple tumors, 219 (24.6%) had a maximal tumor size >3 cm, and 22 (2.5%) had portal vein tumor thrombosis. The median AFP level after achieving a CR was 6.36 ng/mL. After a CR, 473 (53.1%) patients experienced recurrence, and 417 (46.9%) died [median progression-free survival (PFS) and overall survival (OS) of 16.3 and 62.8 months, respectively]. High AFP levels at CR (>20 ng/mL) were independently associated with a shorter PFS [hazard ratio (HR)=1.403] and OS (HR=1.284), together with tumor multiplicity at TACE (HR=1.518 and 1.666, respectively). AFP non-responders at CR (76.2%, n=359 of 471) showed a shorter PFS (median 10.5 months vs. 15.5 months, HR=1.375) and OS (median 41.4 months vs. 61.8 months, HR=1.424) than AFP responders (all p=0.001). 
		                        		
		                        			Conclusion
		                        			High AFP levels and AFP non-responders were independently associated with poor outcomes after TACE. AFP holds clinical implications for detailed risk stratification upon achieving a CR after TACE. 
		                        		
		                        		
		                        		
		                        	
2.Subclinical Hypothyroidism Affects the Long-Term Outcomes of Patients Who Undergo Coronary Artery Bypass Grafting Surgery but Not Heart Valve Surgery
Hana KIM ; Sung Hye KONG ; Jae Hoon MOON ; Sang Yoon KIM ; Kay-Hyun PARK ; Jun Sung KIM ; Joong Haeng CHOH ; Young Joo PARK ; Cheong LIM
Endocrinology and Metabolism 2020;35(2):308-318
		                        		
		                        			 Background:
		                        			The aim of this study was to determine the associations between subclinical hypothyroidism (SCH) and long-term cardiovascular outcomes after coronary artery bypass grafting (CABG) or heart valve surgery (HVS). 
		                        		
		                        			Methods:
		                        			We retrospectively reviewed and compared all-cause mortality, cardiovascular mortality, and cardiovascular events in 461 patients who underwent CABG and 104 patients who underwent HVS. 
		                        		
		                        			Results:
		                        			During a mean±standard deviation follow-up duration of 7.6±3.8 years, there were 187 all-cause deaths, 97 cardiovascular deaths, 127 major adverse cardiovascular events (MACE), 11 myocardial infarctions, one unstable angina, 70 strokes, 30 hospitalizations due to heart failure, 101 atrial fibrillation, and 33 coronary revascularizations. The incidence of all-cause mortality after CABG was significantly higher in patients with SCH (n=36, 55.4%) than in euthyroid patients (n=120, 30.3%), with a hazard ratio of 1.70 (95% confidence interval, 1.10 to 2.63; P=0.018) after adjustment for age, sex, current smoking status, body mass index, underlying diseases, left ventricular dysfunction, and emergency operation. Interestingly, low total triiodothyronine (T3) levels in euthyroid patients who underwent CABG were significantly associated with increased risks of all-cause mortality, cardiovascular mortality, and MACE, but those associations were not observed in HVS patients. Both free thyroxine and thyroid-stimulating hormone levels in euthyroid patients were not related with any cardiovascular outcomes in either the CABG or HVS group. 
		                        		
		                        			Conclusion
		                        			SCH or low total T3 might be associated with a poor prognosis after CABG, but not after HVS, implying that preoperative thyroid hormonal status may be important in ischemic heart disease patients. 
		                        		
		                        		
		                        		
		                        	
3.Descending Aorta Blood Flow Characteristics before the Development of Necrotizing Enterocolitis in Preterm Neonates.
Kyung Min KIM ; Hyo Sup KIM ; Ji Hong YOON ; Eun Jung LEE ; Sook Kyung YUM ; Cheong Jun MOON ; Young Ah YOUN ; Yoo Jin KWUN ; Jae Young LEE ; In Kyung SUNG
Neonatal Medicine 2018;25(2):78-84
		                        		
		                        			
		                        			PURPOSE: To investigate the hemodynamic risk factors for necrotizing enterocolitis (NEC), we analyzed the characteristics of descending aorta (DA) blood flow in preterm neonates, who later developed NEC. METHODS: This was an observational case-control study on 53 preterm neonates at a tertiary referral center. Clinical and echocardiographic data were collected from 23 preterm neonates with NEC (NEC group), and compared with those of 30 preterm neonates without NEC (control group). Echocardiography was done at a median (interquartile range) of 5 (3–9) days after birth and 2 (1–2.5) days before the diagnosis of NEC. RESULTS: Basic clinical characteristics including gestational age, birth weight, Apgar score, breast feeding status, use of umbilical catheters, and mode of invasive ventilator care were similar between the groups. Compared with the control group, the lowest diastolic velocity of DA was significantly decreased, whereas the diastolic reverse flow and the ratio of diastolic reverse to systolic forward flows were significantly increased in the NEC group. In addition, the resistive index (RI) of DA was significantly increased in the NEC group and showed a positive association with the development of NEC. Multivariate logistic regression analysis showed that increasing RI of DA was an independent risk factor for the development of NEC (P=0.008). CONCLUSION: Significant changes in DA flow characteristics including decreased diastolic velocity and increased diastolic reverse flow along with increased peripheral vascular resistance were observed before the development of NEC in preterm neonates. These findings may help clinicians stratify in advance neonates at a risk of developing NEC and may help improve outcomes in these neonates.
		                        		
		                        		
		                        		
		                        			Aorta, Thoracic*
		                        			;
		                        		
		                        			Apgar Score
		                        			;
		                        		
		                        			Birth Weight
		                        			;
		                        		
		                        			Breast Feeding
		                        			;
		                        		
		                        			Case-Control Studies
		                        			;
		                        		
		                        			Catheters
		                        			;
		                        		
		                        			Critical Care
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Echocardiography
		                        			;
		                        		
		                        			Enterocolitis, Necrotizing*
		                        			;
		                        		
		                        			Gestational Age
		                        			;
		                        		
		                        			Hemodynamics
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Infant, Newborn*
		                        			;
		                        		
		                        			Logistic Models
		                        			;
		                        		
		                        			Parturition
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Splanchnic Circulation
		                        			;
		                        		
		                        			Tertiary Care Centers
		                        			;
		                        		
		                        			Vascular Resistance
		                        			;
		                        		
		                        			Ventilators, Mechanical
		                        			
		                        		
		                        	
4.Usefulness of Abdominal Sonography in Accurate Diagnosis for Necrotizing Enterocolitis.
Cheong Jun MOON ; Gye Yeon LIM ; So Young KIM ; In Kyung SUNG ; Young Ah YOUN ; Sook Kyung YUM
Neonatal Medicine 2015;22(2):92-97
		                        		
		                        			
		                        			PURPOSE: The purpose of this study was to examine the usefulness of abdominal sonography in the diagnosis of necrotizing enterocolitis (NEC). METHODS: We reviewed the medical records of 51 neonates who were diagnosed with NEC in the neonatal intensive care unit at Yeouido St. Mary's Hospital of the Catholic University in Korea between January 2008 and December 2012. The neonates underwent abdominal ultrasonography on the day of their diagnosis and on the third day after diagnosis. Simple abdominal radiography was performed on the same day as the sonography. The neonates were diagnosed with NEC in accordance with the abdominal sonographic findings. Abdominal radiography and sonography were used to assess the NEC stages in the neonates. RESULTS: On the day of NEC diagnosis by abdominal sonography, 50 neonates were diagnosed with stage II NEC and 1 was diagnosed with stage III NEC. However, simple radiography diagnosed 49 neonates with stage I NEC, 1 with stage II NEC, and 1 with stage III NEC. On the third day after NEC diagnosis by abdominal sonography, 48 neonates were diagnosed with stage II NEC and 3 were diagnosed with stage III NEC. On the other hand, simple radiography diagnosed 26 neonates with stage I NEC, 24 with stage II NEC, and 1 with stage III NEC. CONCLUSION: Abdominal sonography can be used as a tool for accurately diagnosing NEC and treating neonates showing ambiguous symptoms during the early stages of NEC.
		                        		
		                        		
		                        		
		                        			Diagnosis*
		                        			;
		                        		
		                        			Early Diagnosis
		                        			;
		                        		
		                        			Enterocolitis, Necrotizing*
		                        			;
		                        		
		                        			Hand
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Infant, Newborn
		                        			;
		                        		
		                        			Intensive Care, Neonatal
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Medical Records
		                        			;
		                        		
		                        			Radiography
		                        			;
		                        		
		                        			Radiography, Abdominal
		                        			;
		                        		
		                        			Ultrasonography
		                        			
		                        		
		                        	
5.Risk Factors for Severity of Intraventricular Hemorrhage in Very Low Birth Weight Infants and Neurodevelopmental Outcomes.
Mi Kyung CHEON ; Sook Kyung YUM ; Cheong Jun MOON ; Young Ah YOUN ; So Young KIM ; In Kyung SUNG
Korean Journal of Perinatology 2014;25(4):266-275
		                        		
		                        			
		                        			PURPOSE: The purpose of this study is to investigate the perinatal risk factors for severity of intraventricular hemorrhage (IVH) in very low birth weight infants (VLBWIs) and to study the following neurodevelopmental outcomes depending on the degree of IVH severity. METHODS: The retrospective study included 145 VLBWIs who were admitted at Seoul St. Mary's Hospital between May of 2009 and April of 2013. Prenatal, obstetric and postnatal risk factors for IVH were investigated. VLBWIs were divided into the group of IVH grade 1-2 and IVH grade 3-4. During this study period, 26 VLBWIs were died and 11 VLBWIs were lost to followed up, thereby 108 infants were included in the final analysis. They were regularly followed up and assessed for presence of major neurodevelopmental impairments including cognitive impairment, cerebral palsy, visual deficit, hearing deficit, and epilepsy. Among 108 infants, 23 (21.3%) patients had neurodevelopmental impairments. RESULTS: The lower gestational age and birth weight were significant prenatal risk factors for severe IVH. Lower Apgar score at 1 and 5 min, hypotension/shock, higher levels of partial pressure of carbon dioxide, presence of patent ductus arteriosus, pneumothorax, thrombocytopenia, necrotizing enterocolitis, and bronchopulmonary dysplasia were significant postnatal risk factors for severe IVH. After multiple logistic regression analysis, gestational age, birth weight, and hypotension/shock were independent risk factors for severe IVH. The incidence of major neurodevelopmental impairments were also significantly higher in VLBWIs who survived after severe IVH. CONCLUSION: In addition to preterm birth, minimizing hypotension/shock, the risk factor of severe IVH, is important to prevent major neurodevelopmental impairments in VLBWIs.
		                        		
		                        		
		                        		
		                        			Apgar Score
		                        			;
		                        		
		                        			Birth Weight
		                        			;
		                        		
		                        			Bronchopulmonary Dysplasia
		                        			;
		                        		
		                        			Carbon Dioxide
		                        			;
		                        		
		                        			Cerebral Palsy
		                        			;
		                        		
		                        			Ductus Arteriosus, Patent
		                        			;
		                        		
		                        			Enterocolitis, Necrotizing
		                        			;
		                        		
		                        			Epilepsy
		                        			;
		                        		
		                        			Gestational Age
		                        			;
		                        		
		                        			Hearing
		                        			;
		                        		
		                        			Hemorrhage*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Infant*
		                        			;
		                        		
		                        			Infant, Newborn
		                        			;
		                        		
		                        			Infant, Very Low Birth Weight*
		                        			;
		                        		
		                        			Logistic Models
		                        			;
		                        		
		                        			Partial Pressure
		                        			;
		                        		
		                        			Pneumothorax
		                        			;
		                        		
		                        			Premature Birth
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Risk Factors*
		                        			;
		                        		
		                        			Seoul
		                        			;
		                        		
		                        			Thrombocytopenia
		                        			
		                        		
		                        	
6.Partial Seizures Manifesting as Apnea Only in Preterm Infant.
Ja Kyung JUN ; Cheong Jun MOON ; Soon Ju KIM ; Young Ah YOUN ; Ju Young LEE ; Hyun Seung LEE ; Jung Hyun LEE ; In Kyung SUNG ; So Young KIM
Neonatal Medicine 2013;20(1):106-112
		                        		
		                        			
		                        			PURPOSE: Extremely-low-birth-weight infants (ELBWIs), especially those < or =24 gestational weeks (GW), presented extremes in IWL and changes of water balance. The purpose of the present study was to retrospectively investigate fluid and electrolyte balance in infants of < or =24-GW during the first postnatal week under high humidification. METHODS: Medical records of extremely-low-birth-weight infants (ELBWIs) who were born and admitted to the Neonatal Intensive Care Unit at Samsung Medical Center during March 2004-September 2010 were reviewed. Fluid intake, urine output, insensible water loss (IWL), and electrolyte balance of 22-GW (n=14), 23-GW (n=40), and 24-GW (n=67) infants nursed in high humidity (95%) were compared with > or =26-GW (n=65) infants nursed in 60% humidity. RESULTS: Survival rate until discharge was 33%, 82%, 75%, and 89.3% in 22-GW, 23-GW, 24-GW, and > or =26-GW infants, respectively. Fluid intake and IWL was higher in 22-GW and 23-WG, but not different in 24-GW, than in > or =26-GW infants. At postnatal days (P) 3-5, the urine output was significantly lower in > or =26-GW infants than in the other age groups. Serum sodium level was significantly higher in 22-, 23-, and 24-GW (P1-2) than in > or =26-GW infants. Hypernatremia (>150 mEq/dl sodium) was more frequent in 22-GW (71%), 23-GW (41%), and 24-GW (21%) than in > or =26-GW infants (14%). CONCLUSION: High-humidity environments significantly decreased fluid intake and improved electrolyte imbalance in 24-GW, but not 22- and 23-GW, infants. Increased IWL in the latter might be related to more immature skin, and implicates the need for additional nurturing conditions.
		                        		
		                        		
		                        		
		                        			Apnea
		                        			;
		                        		
		                        			Electrolytes
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Humidity
		                        			;
		                        		
		                        			Hypernatremia
		                        			;
		                        		
		                        			Infant
		                        			;
		                        		
		                        			Infant, Newborn
		                        			;
		                        		
		                        			Infant, Premature
		                        			;
		                        		
		                        			Intensive Care, Neonatal
		                        			;
		                        		
		                        			Medical Records
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Seizures
		                        			;
		                        		
		                        			Skin
		                        			;
		                        		
		                        			Sodium
		                        			;
		                        		
		                        			Survival Rate
		                        			;
		                        		
		                        			Water Loss, Insensible
		                        			;
		                        		
		                        			Water-Electrolyte Balance
		                        			
		                        		
		                        	
7.Negative pressure wound therapy for inguinal lymphatic complications in critically ill patients.
Yong Kyu CHEONG ; Heungman JUN ; Yong Pil CHO ; Gi Won SONG ; Ki Myung MOON ; Tae Won KWON ; Sung Gyu LEE
Journal of the Korean Surgical Society 2013;85(3):134-138
		                        		
		                        			
		                        			PURPOSE: In this study, we investigated the therapeutic potential of regulated negative pressure vacuum-assisted wound therapy for inguinal lymphatic complications in critically ill, liver transplant recipients. METHODS: The great saphenous vein was harvested for hepatic vein reconstruction during liver transplantation in 599 living-donor liver transplant recipients. Fourteen of the recipients (2.3%) developed postoperative inguinal lymphatic complications and were treated with negative pressure wound therapy, and they were included in this study. RESULTS: The average total duration of negative pressure wound therapy was 23 days (range, 11 to 42 days). Complete resolution of the lymphatic complications and wound healing were achieved in all 14 patients, 5 of whom were treated in hospital and 9 as outpatients. There was no clinically detectable infection, bleeding or recurrence after an average follow-up of 27 months (range, 7 to 36 months). CONCLUSION: Negative pressure wound therapy is an effective, readily-available treatment option that is less invasive than exploration and ligation of leaking lymphatics and provides good control of drainage and rapid wound closure in critically ill patients.
		                        		
		                        		
		                        		
		                        			Critical Illness
		                        			;
		                        		
		                        			Drainage
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Hemorrhage
		                        			;
		                        		
		                        			Hepatic Veins
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Ligation
		                        			;
		                        		
		                        			Liver
		                        			;
		                        		
		                        			Liver Transplantation
		                        			;
		                        		
		                        			Negative-Pressure Wound Therapy
		                        			;
		                        		
		                        			Outpatients
		                        			;
		                        		
		                        			Recurrence
		                        			;
		                        		
		                        			Saphenous Vein
		                        			;
		                        		
		                        			Transplants
		                        			;
		                        		
		                        			Wound Healing
		                        			
		                        		
		                        	
8.Revision and update on clinical practice guideline for liver cirrhosis.
Ki Tae SUK ; Soon Koo BAIK ; Jung Hwan YOON ; Jae Youn CHEONG ; Yong Han PAIK ; Chang Hyeong LEE ; Young Seok KIM ; Jin Woo LEE ; Dong Joon KIM ; Sung Won CHO ; Seong Gyu HWANG ; Joo Hyun SOHN ; Moon Young KIM ; Young Bae KIM ; Jae Geun KIM ; Yong Kyun CHO ; Moon Seok CHOI ; Hyung Joon KIM ; Hyun Woong LEE ; Seung Up KIM ; Ja Kyung KIM ; Jin Young CHOI ; Dae Won JUN ; Won Young TAK ; Byung Seok LEE ; Byoung Kuk JANG ; Woo Jin CHUNG ; Hong Soo KIM ; Jae Young JANG ; Soung Won JEONG ; Sang Gyune KIM ; Oh Sang KWON ; Young Kul JUNG ; Won Hyeok CHOE ; June Sung LEE ; In Hee KIM ; Jae Jun SHIM ; Gab Jin CHEON ; Si Hyun BAE ; Yeon Seok SEO ; Dae Hee CHOI ; Se Jin JANG
The Korean Journal of Hepatology 2012;18(1):1-21
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        			Antiviral Agents/therapeutic use
		                        			;
		                        		
		                        			Ascites/diagnosis/prevention & control/therapy
		                        			;
		                        		
		                        			Cholagogues and Choleretics/therapeutic use
		                        			;
		                        		
		                        			Fatty Liver/diagnosis/diet therapy
		                        			;
		                        		
		                        			Fatty Liver, Alcoholic/diagnosis/drug therapy
		                        			;
		                        		
		                        			Hemorrhage/prevention & control/therapy
		                        			;
		                        		
		                        			Hepatic Encephalopathy/diagnosis/prevention & control/therapy
		                        			;
		                        		
		                        			Hepatitis B, Chronic/diagnosis/drug therapy
		                        			;
		                        		
		                        			Hepatitis C, Chronic/diagnosis/drug therapy
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Liver Cirrhosis/*diagnosis/drug therapy/pathology/*therapy
		                        			;
		                        		
		                        			Liver Cirrhosis, Biliary/drug therapy
		                        			;
		                        		
		                        			Vasodilator Agents/therapeutic use
		                        			
		                        		
		                        	
9.Differentiation of human labia minora dermis-derived fibroblasts into insulin-producing cells.
Bona KIM ; Byung Sun YOON ; Jai Hee MOON ; Jonggun KIM ; Eun Kyoung JUN ; Jung Han LEE ; Jun Sung KIM ; Cheong Soon BAIK ; Aeree KIM ; Kwang Youn WHANG ; Seungkwon YOU
Experimental & Molecular Medicine 2012;44(1):26-35
		                        		
		                        			
		                        			Recent evidence has suggested that human skin fibroblasts may represent a novel source of therapeutic stem cells. In this study, we report a 3-stage method to induce the differentiation of skin fibroblasts into insulin-producing cells (IPCs). In stage 1, we establish the isolation, expansion and characterization of mesenchymal stem cells from human labia minora dermis-derived fibroblasts (hLMDFs) (stage 1: MSC expansion). hLMDFs express the typical mesenchymal stem cell marker proteins and can differentiate into adipocytes, osteoblasts, chondrocytes or muscle cells. In stage 2, DMEM/F12 serum-free medium with ITS mix (insulin, transferrin, and selenite) is used to induce differentiation of hLMDFs into endoderm-like cells, as determined by the expression of the endoderm markers Sox17, Foxa2, and PDX1 (stage 2: mesenchymal-endoderm transition). In stage 3, cells in the mesenchymal-endoderm transition stage are treated with nicotinamide in order to further differentiate into self-assembled, 3-dimensional islet cell-like clusters that express multiple genes related to pancreatic beta-cell development and function (stage 3: IPC). We also found that the transplantation of IPCs can normalize blood glucose levels and rescue glucose homeostasis in streptozotocin-induced diabetic mice. These results indicate that hLMDFs have the capacity to differentiate into functionally competent IPCs and represent a potential cell-based treatment for diabetes mellitus.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Biological Markers/metabolism
		                        			;
		                        		
		                        			*Cell Culture Techniques
		                        			;
		                        		
		                        			*Cell Differentiation
		                        			;
		                        		
		                        			Cell Proliferation/drug effects
		                        			;
		                        		
		                        			Cell Separation
		                        			;
		                        		
		                        			Cells, Cultured
		                        			;
		                        		
		                        			Dermis/*cytology/drug effects
		                        			;
		                        		
		                        			Diabetes Mellitus, Experimental/*surgery
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Fibroblasts/*cytology/drug effects
		                        			;
		                        		
		                        			Genitalia, Female/*cytology
		                        			;
		                        		
		                        			Glucose/metabolism
		                        			;
		                        		
		                        			Hepatocyte Nuclear Factor 3-beta/metabolism
		                        			;
		                        		
		                        			Homeodomain Proteins/metabolism
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Insulin/pharmacology/secretion
		                        			;
		                        		
		                        			Insulin-Secreting Cells/*cytology/metabolism
		                        			;
		                        		
		                        			*Islets of Langerhans Transplantation
		                        			;
		                        		
		                        			Mesenchymal Stem Cells/*cytology/drug effects/metabolism
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Nude
		                        			;
		                        		
		                        			Niacinamide/pharmacology
		                        			;
		                        		
		                        			Recovery of Function
		                        			;
		                        		
		                        			SOXF Transcription Factors/metabolism
		                        			;
		                        		
		                        			Sodium Selenite/pharmacology
		                        			;
		                        		
		                        			Trans-Activators/metabolism
		                        			;
		                        		
		                        			Transferrin/pharmacology
		                        			
		                        		
		                        	
10.Clinical Characteristics of a Nationwide Hospital-based Registry of Mild-to-Moderate Alzheimer's Disease Patients in Korea: A CREDOS (Clinical Research Center for Dementia of South Korea) Study.
Hee Kyung PARK ; Duk L NA ; Seol Heui HAN ; Ji Young KIM ; Hae Kwan CHEONG ; Seong Yoon KIM ; Sang Yun KIM ; Chang Hyung HONG ; Do Kwan KIM ; Bon D KU ; So Young MOON ; Jun Young LEE ; Yong S SHIM ; Young Chul YOUN ; Eun Joo KIM ; Beoung Chae KIM ; Kee Hyung PARK ; Kyung R CHA ; Sang Won SEO ; Jae Hong LEE
Journal of Korean Medical Science 2011;26(9):1219-1226
		                        		
		                        			
		                        			With rapid population aging, the socioeconomic burden caused by dementia care is snowballing. Although a few community-based studies of Alzheimer's disease (AD) have been performed in Korea, there has never been a nationwide hospital-based study thereof. We aimed to identify the demographics and clinical characteristics of mild-to-moderate AD patients from the Clinical Research Center for Dementia of Korea (CREDOS) registry. A total of 1,786 patients were consecutively included from September 2005 to June 2010. Each patient underwent comprehensive neurological examination, interview for caregivers, laboratory investigations, neuropsychological tests, and brain MRI. The mean age was 74.0 yr and the female percentage 67.0%. The mean period of education was 7.1 yr and the frequency of early-onset AD (< 65 yr old) was 18.8%. Among the vascular risk factors, hypertension (48.9%) and diabetes mellitus (22.3%) were the most frequent. The mean score of the Korean version of Mini-Mental State Examination (K-MMSE) was 19.2 and the mean sum of box scores of Clinical Dementia Rating (CDR-SB) 5.1. Based on the well-structured, nationwide, and hospital-based registry, this study provides the unique clinical characteristics of AD and emphasizes the importance of vascular factors in AD in Korea.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Aged, 80 and over
		                        			;
		                        		
		                        			Alzheimer Disease/complications/*diagnosis
		                        			;
		                        		
		                        			Brain/radionuclide imaging
		                        			;
		                        		
		                        			Caregivers
		                        			;
		                        		
		                        			Dementia/diagnosis
		                        			;
		                        		
		                        			Demography
		                        			;
		                        		
		                        			Diabetes Mellitus, Type 2/etiology
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hospitals
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypertension/etiology
		                        			;
		                        		
		                        			Interviews as Topic
		                        			;
		                        		
		                        			Magnetic Resonance Imaging
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Questionnaires
		                        			;
		                        		
		                        			*Registries
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Risk Factors
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail